Occurrence of Dyskalemia With Treatment for Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1090 participants.
Also called NCT05155436
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,090 participants
- Sponsor
- Registry
-
NCT05155436
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Bangladesh
- Registry status
- Completed
Technical summary
Registry record NCT05155436. Allocation not applicable; no masking; primary purpose treatment. Start 2022-01-15 (actual); primary completion 2023-03-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Occurrence of Dyskalemia With Treatment for Hypertension
- Acronym
- OK
- Condition
- Hypertension
- Condition
- Potassium Imbalance
- Intervention (Drug)
- Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg
- Lead sponsor
- National Heart Foundation of Bangladesh
- Collaborator
- National Heart Foundation Hospital and Research Institute of Bangladesh
- Collaborator
- Johns Hopkins University
- Collaborator
- Resolve to Save Lives
Record details
- Record id
cardio:ct-nct05155436- Content hash
953ca7c8992960ba04893dc9d8ad2a7100ff4456b543b29a0495452039ba1fe7